Search results (16)
« Back to News & EventsFirst trial of vaccine to prevent Lynch syndrome-associated cancers approved to start in Oxford
9 Jun, 2026
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.
Early-phase study demonstrates safety and immune response of therapeutic HPV vaccine
24 Feb, 2026
An early-phase clinical trial led by Associate Professor Karin Hellner has reported results evaluating a new therapeutic vaccine designed to help the body clear high-risk human papillomavirus (HPV) infection in women with low-grade cervical lesions.
Professor Sarah Blagden shares cutting-edge precision prevention research at Oxford in new Channel 4 Documentary
21 Nov, 2025
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
World’s first lung cancer prevention vaccine gets £2 million for clinical trial
19 Nov, 2025
People at high risk of lung cancer will soon be able to receive the first-ever experimental vaccine, 'LungVax', designed to prevent the disease, in a world-first clinical trial. The LungVax vaccine carries a series of genetic instructions which train the immune system to recognise tumour antigens on the surface of abnormal lung cells.
Professor Sarah Blagden to star in New Landmark Channel 4 Documentary Series 'Cancer Detectives: Finding the Cures'
16 Oct, 2025
Channel 4 today announces 'Cancer Detectives: Finding the Cures', an observational documentary series that will explore the pioneering research that could transform the future of cancer detection, treatment and prevention.
New vaccines that aim to prevent cancer: Starting the conversation
11 Jun, 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
CRUK funding for therapeutic HPV vaccine to prevent HPV-associated cancers
25 Mar, 2025
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK
21 Mar, 2025
David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
27 Jan, 2025
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Oxford Centre for Cancer Early Detection and Prevention celebrates 5 years at its 2024 Symposium
3 Jan, 2025
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford’s most successful cancer early detection and prevention programmes.
Funding to create world's first ovarian cancer prevention vaccine
4 Oct, 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 Sep, 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.
Oxford hosts industry event on cancer precision prevention trials
17 Jul, 2024
Professor Sarah Blagden led a panel discussion focused on the opportunities of cancer precision prevention.
OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
4 Jul, 2024
Over 20 Oxford researchers engaged with over 350 attendees from all over the world at a truly interdisciplinary cancer prevention conference.
£1.7 million for vaccine to prevent lung cancer
22 Mar, 2024
Oxford and UCL researchers seeking to create the world’s first vaccine to prevent lung cancer in people at high risk of the disease have been granted up to £1.7 million from Cancer Research UK and the CRIS Cancer Foundation.
Oxford Cancer Precision Prevention Symposium – a recap
1 Dec, 2023
To celebrate the launch of the UK’s first CRUK clinical trials unit dedicated to cancer precision prevention in Oxford, we held a research symposium that highlighted the spectra of Cancer Precision Prevention clinical programmes across the UK.